OPC Pharmaceutical Share Price

Equities

OPC

VN000000OPC9

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
24,700 VND 0.00% Intraday chart for OPC Pharmaceutical 0.00% +2.92%

Financials

Sales 2022 1,172B 46.86M 3.72B Sales 2023 1,005B 40.2M 3.19B Capitalization 1,537B 61.49M 4.88B
Net income 2022 142B 5.69M 451M Net income 2023 122B 4.89M 388M EV / Sales 2022 1.23 x
Net cash position 2022 315B 12.61M 1B Net cash position 2023 321B 12.85M 1.02B EV / Sales 2023 1.21 x
P/E ratio 2022
13.8 x
P/E ratio 2023
14.7 x
Employees 926
Yield 2022
5.45%
Yield 2023
-
Free-Float 59.18%
More Fundamentals * Assessed data
Dynamic Chart
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
OPC Pharmaceutical Joint Stock Company Receives the Resignation from Duong Minh Hung as Sales and Marketing Deputy Chief Executive Officer CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
OPC Pharmaceutical Joint Stock Company Appoints Mrs. Nguyen Thi Hong the Person in Charge of Corporate Governance Cum Secretary CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
OPC Pharmaceutical Joint Stock Company Announces the Resignation of Le Van Son as Chairman of the BOD CI
OPC Pharmaceutical Joint Stock Company Announces the Remaining Cash Dividend in 2023, Payable on May 25, 2023 CI
Opc Pharmaceutical Joint Stock Company Announces Executive Changes CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
OPC Pharmaceutical Joint Stock Company Approves to Pay the First Cash Dividend for 2022, Payment Date: April 26, 2023 CI
OPC Pharmaceutical Joint Stock Company Announces Management Resignations CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
OPC Pharmaceutical Joint Stock Company Appoints Phuong Thanh Nhung as Deputy Chairman of the Board of Director CI
OPC Pharmaceutical Joint Stock Company Appoints Duong Minh Hung as Deputy CEO CI
More news
Current month+5.11%
1 month+5.11%
3 months+7.39%
6 months+7.39%
Current year+2.92%
More quotes
1 week
23 850.00
Extreme 23850
24 700.00
1 month
23 000.00
Extreme 23000
25 650.00
Current year
22 400.00
Extreme 22400
25 650.00
1 year
21 550.00
Extreme 21550
25 650.00
3 years
21 550.00
Extreme 21550
30 700.00
5 years
17 012.45
Extreme 17012.4481
30 700.00
10 years
11 203.32
Extreme 11203.3195
30 700.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 13/07/21
Chief Administrative Officer - -
Corporate Officer/Principal 54 01/05/11
Members of the board TitleAgeSince
Director/Board Member 68 31/12/77
Director/Board Member 48 21/10/21
Chairman - 21/10/21
More insiders
Date Price Change Volume
26/04/24 24,700 0.00% 2,800
25/04/24 24,700 0.00% 1,300
24/04/24 24,700 0.00% 4,200
23/04/24 24,700 0.00% 400

End-of-day quote Ho Chi Minh S.E., April 25, 2024

More quotes
OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.
More about the company